Office-use compounding in District of Columbia

What the rule requires in practice

Each item carries a confidence level. Verbatim rule text is high confidence; a reading of how two provisions interact, or a source that could not be re-verified, is not.

The compounding definition has three branches and no office-use branchHigh confidence

The District defines compounding as preparation, mixing, assembling, packaging or labelling of a drug or device as the result of a practitioner’s prescription drug order; or for the purpose of, or as an incident to, research, teaching or chemical analysis and not for sale or dispensing; and it adds preparation in anticipation of prescription drug orders based on routine, regularly observed prescribing patterns. Every branch is tied to orders. There is no branch for stock supplied to a practitioner, which is why the question gets answered by the wholesaler definition instead of by the compounding rule.That definition sits at 22-B DCMR § 1999 and took its current form on 1 April 2022. Note the subtitle letter: plain "22 DCMR" is the pre-renumbering form and does not resolve to this chapter.

A District pharmacy may handle only FDA-registered productHigh confidence

The chapter’s opening rule provides that a pharmacy shall stock, maintain, sell, compound, dispense and distribute only FDA-registered drugs, medical devices and chemicals for compounding. That is a condition on what may be handled at all, and it sits upstream of every question on this page.Reported rather than block-quoted, for the same reason as the definition above: the District publishes each section’s text only through its own viewer, so there is no address at which a reader — or our own link checker — can open the words themselves. The citation below points at the section record, which carries the section number, its chapter and the rulemaking that adopted it.

There is no outsourcing-facility category in the District, under any nameHigh confidence

This is the difference between the District and every other entry that routes office use to a facility type. Its licensing checklist enumerates the facility subtypes it covers — a virtual facility, a reverse distributor, a third-party logistics provider, a re-packager, a researcher, a warehouse — and names none of them an outsourcing facility. The words "outsourcing" and "503B" do not appear in that document at all. What captures an outsourcing facility is the catch-all, "or any other facility that intends to ship prescription drugs". So a 503B ships into the District on a generic wholesaler registration, not on a credential written for what it is.

The named board does the least of the four bodies involvedHigh confidence

The Board of Pharmacy licenses pharmacists — natural persons. It does not license pharmacies. Pharmacy facilities, drug manufacturer and wholesaler registrations and controlled-substance registrations all run through DC Health’s Pharmaceutical Control Division, inside its Health Regulation and Licensing Administration. Every business also needs a Basic Business Licence from a fourth body, the Department of Licensing and Consumer Protection. Anyone checking "the Board of Pharmacy" for a facility answer here is checking the wrong desk.That fourth body used to be the Department of Consumer and Regulatory Affairs. It was redesignated — renamed, not abolished — by D.C. Law 23-269, effective 5 April 2021, with the operational transition later moved to 1 October 2022.

A live statute commands a licence form that no longer existsHigh confidence

The pharmacy licensing statute still directs that any licence issued under it be issued as a "Public Health: Pharmacy and Pharmaceuticals endorsement" to a basic business licence. Its history line ends in 2012 and it has not been amended since. The business licence categories were collapsed with effect from 1 October 2025 and that endorsement is no longer among them — the large pharmacy chains now hold ordinary General Business licences. The statutory command survives the category it names.

The five per cent clause runs backwards and has no floor beneath itHigh confidence

Read it carefully, because it is the opposite shape to almost every percentage clause in this file. It is not an exemption and there is nothing to shelter under: a pharmacy that sells more than five per cent of its drug inventory to a hospital or other pharmacy is pulled into the wholesaler definition and into the licence requirement. It is measured on inventory rather than on sales or revenue, and it states no period at all. And it does not reach this question anyway — its recipients are a hospital or another pharmacy, and a physician’s office is neither. Supply to a practice is caught by the trailing clause instead, which carries no percentage at all.

The labelling rule cannot be satisfied by office stockHigh confidence

A container in which a prescription drug is sold or dispensed must bear, among other things, the name of the patient and the serial number of the prescription. Stock held for a practitioner to administer has neither, so the District’s label rule has nothing to say to it — which is another way of seeing that the regulations were not drafted with this transaction in mind.

Compounding standards arrived in 2022, and an older copy is still circulatingHigh confidence

A final rulemaking effective 1 April 2022 rebuilt the pharmacy chapter and brought in the USP compounding chapters. The trap is that DC Health hosts, on its own site and linked from its own licensing pages, a copy of the pharmacy regulations that predates that rewrite by well over a decade. It looks entirely legitimate and its section numbers no longer match the current regulations. Check any District regulation citation against the official publisher before relying on it.

Last change, and what has not changedHigh confidence

The pharmacy chapter took its current form on 1 April 2022, and the business licence categories were collapsed with effect from 1 October 2025. The Board of Pharmacy has published nothing on this question: its policy statements cover other subjects entirely, and its agendas and minutes across 2025 and 2026 contain no discussion of compounding, office use or outsourcing facilities.

District of Columbia at a glance

Receiving 503B office stock in District of Columbia

The District is the entry where naming the right agency is most of the work. Four bodies are involved, the one called the Board of Pharmacy licenses only people, and the credential an outsourcing facility needs is not written for outsourcing facilities.

Everything above this heading answers the supply question: may a state-licensed 503A pharmacy ship non-patient-specific stock? This section answers the other half. Registration with FDA under section 503B is a federal exemption from federal law and preempts no state licensing scheme, so it is never the whole answer on its own — a state credential is the norm rather than the exception, it is not always issued by the board of pharmacy, and in some states the category you would search for does not exist. What District of Columbia asks for is set out below, including where we could not establish it.

What the 503B must hold to ship inHigh confidence

A District Drug Manufacturer, Distributor and Wholesaler registration, issued by DC Health’s Pharmaceutical Control Division, with a separate application for each location that will ship drug products into or within the District. There is no outsourcing facility class to apply for; the checklist’s catch-all for any other facility intending to ship prescription drugs is what captures one.Fees are published by the agency on that checklist rather than set in statute or regulation — the statute says only that the required fee is payable. Treat any figure as an agency number with a date on it, and check the current checklist.

Does your practice need a permit?Medium confidence

No health-facility permit exists in the District for a physician’s office, clinic or med spa to hold compounded stock, and we found none. A practice holds a Basic Business Licence from the Department of Licensing and Consumer Protection, per location, like any other District business. Whether a clinic needs a separate health-care facility licence to operate at all is a different question and is beyond the scope of this page.

Administer vs dispenseMedium confidence

The District decides this before the practitioner acts. The carve-out from "Manufacture" covers compounding incidental to administering or dispensing in the course of professional practice, and the wholesaler definition turns on distribution to someone who is not a consumer or a patient. So the classification attaches to the shipment rather than to what is later done with it, and a practice that only administers is on the same side of the line as one that dispenses.

Scheduled (controlled) stockLow confidence

The District issues its own controlled-substance registration through the same Pharmaceutical Control Division, additive to the federal one, and its licensing material treats it as required per facility with its own application fee. The registration term is worth confirming directly with the agency: the regulation text and the agency’s current forms do not agree with each other on whether it runs annually or biennially.Held deliberately at low confidence. The current text of the District’s controlled-substances chapter could not be retrieved from the official publisher, and the only full copy available to us is the superseded one described in the scope note. The per-location and term details above are therefore reported from the agency’s current licensing material rather than from the regulation.

How to check a facility’s credential before you order is set out in how to place an office-use order.

What this page does not establish

• The conclusion that supplying a practitioner makes a District pharmacy a wholesaler is a reading of two definitions, not a holding. No District guidance, advisory opinion, declaratory ruling or enforcement action applying them to compounded office stock was found, and the Board of Pharmacy’s published material does not touch the subject.
• There is a genuine grammatical question inside the wholesaler definition that we flag rather than resolve: whether the closing clause about distributing to a person other than a consumer or patient governs the whole list of entities or only the last item in it. This page reads it as governing the list, which is the natural reading, but no District case or agency interpretation settling it was found.
• Our reading of the District’s pharmacy chapter is not a full-chapter sweep. The official publisher serves each section’s text only through its own viewer, and a chapter-level page returns a complete-looking table of section headings with no rule text in it at all — so a zero-hit search against that page proves nothing. We hold the full text of only a handful of the chapter’s sections, and while nothing in the remaining headings suggests an office-use provision, we do not claim to have read them.
• One warning if you check the District yourself. DC Health hosts its own copy of the pharmacy regulations, linked from its own licensing pages, and that copy predates the 2022 rewrite by well over a decade. Every ordinary integrity check passes on it — correct government host, valid document, plausible text — and its section numbers are wrong for current law. An agency’s hosted copy of its regulations is a convenience copy, not the regulations.
• District fee figures are published by the agency rather than codified, and at least one business-licence provision was under a temporary emergency measure with a printed expiry when this page was written. Take any District fee from the agency’s current material and note the date you took it.
• We searched no case law, attorney-general opinions or disciplinary orders for the District, and search engines were unavailable when it was researched. Read nothing into that silence — it means we have not looked, not that nothing is there.